Total Payments
$168,175
2024 Payments
$45,447
Companies
20
Transactions
139
Medicare Patients
873
Medicare Billing
$134,837
Payment Breakdown by Category
Other$61,726 (36.7%)
Consulting$56,680 (33.7%)
Travel$39,991 (23.8%)
Education$7,000 (4.2%)
Food & Beverage$2,741 (1.6%)
Gifts$36.96 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $56,680 | 28 | 33.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $48,805 | 12 | 29.0% |
| Travel and Lodging | $39,991 | 50 | 23.8% |
| Honoraria | $12,800 | 5 | 7.6% |
| Education | $7,000 | 1 | 4.2% |
| Food and Beverage | $2,741 | 41 | 1.6% |
| Grant | $121.00 | 1 | 0.1% |
| Gift | $36.96 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $82,979 | 44 | $0 (2024) |
| Telix Pharmaceuticals | $51,281 | 38 | $0 (2024) |
| Janssen Research & Development, LLC | $18,578 | 10 | $0 (2023) |
| PFIZER INC. | $6,299 | 5 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $3,579 | 2 | $0 (2019) |
| INTUITIVE SURGICAL, INC. | $2,041 | 17 | $0 (2024) |
| Genentech, Inc. | $1,050 | 1 | $0 (2021) |
| HISTOSONICS,INC. | $971.87 | 4 | $0 (2024) |
| Aveo Pharmaceuticals, Inc. | $302.78 | 2 | $0 (2024) |
| Medtronic USA, Inc. | $253.74 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $45,447 | 49 | Merck Sharp & Dohme LLC ($26,746) |
| 2023 | $65,888 | 33 | Telix Pharmaceuticals ($33,417) |
| 2022 | $31,587 | 22 | Merck Sharp & Dohme LLC ($20,701) |
| 2021 | $14,454 | 14 | Merck Sharp & Dohme Corporation ($8,484) |
| 2020 | $637.63 | 10 | Intuitive Surgical, Inc. ($492.82) |
| 2019 | $2,121 | 4 | E.R. Squibb & Sons, L.L.C. ($1,854) |
| 2018 | $1,762 | 2 | E.R. Squibb & Sons, L.L.C. ($1,725) |
| 2017 | $6,278 | 5 | PFIZER INC. ($6,269) |
All Payment Transactions
139 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Merck Sharp & Dohme LLC | WELIREG (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,725.00 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $79.50 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 11/11/2024 | Aveo Pharmaceuticals, Inc. | FOTIVDA (Drug) | Food and Beverage | In-kind items and services | $134.81 | General |
| Category: Oncology | ||||||
| 11/11/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $74.39 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 10/17/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Education | In-kind items and services | $7,000.00 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 10/17/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 10/09/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,815.00 | General |
| Category: ONCOLOGY | ||||||
| 10/09/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $674.29 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $392.20 | General |
| Category: ONCOLOGY | ||||||
| 09/20/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $221.74 | General |
| Category: ONCOLOGY | ||||||
| 09/19/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug) | Travel and Lodging | Cash or cash equivalent | $753.96 | General |
| Category: PROSTATE CANCER DIAGNOSIS | ||||||
| 09/18/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 09/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,815.00 | General |
| Category: ONCOLOGY | ||||||
| 09/11/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: ONCOLOGY | ||||||
| 09/05/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $617.00 | General |
| Category: ONCOLOGY | ||||||
| 09/05/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Travel and Lodging | In-kind items and services | $554.31 | General |
| Category: ONCOLOGY | ||||||
| 07/29/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Travel and Lodging | Cash or cash equivalent | $463.98 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 07/28/2024 | Telix Pharmaceuticals | ILLUCCIX (Drug), ILLUCCIX | Travel and Lodging | Cash or cash equivalent | $465.98 | General |
| Category: PROSTATE CANCER THERAPY | ||||||
| 07/03/2024 | Merck Sharp & Dohme LLC | WELIREG (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,815.00 | General |
| Category: ONCOLOGY | ||||||
| 07/03/2024 | Merck Sharp & Dohme LLC | WELIREG (Drug) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: ONCOLOGY | ||||||
| 06/30/2024 | HISTOSONICS,INC. | — | Travel and Lodging | Cash or cash equivalent | $185.17 | General |
| 06/18/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $71.40 | General |
| Category: SURGERY | ||||||
| 06/16/2024 | HISTOSONICS,INC. | — | Travel and Lodging | Cash or cash equivalent | $706.94 | General |
| 06/16/2024 | HISTOSONICS,INC. | — | Travel and Lodging | Cash or cash equivalent | $32.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 320 | 373 | $473,254 | $60,961 |
| 2022 | 6 | 246 | 281 | $259,040 | $35,665 |
| 2021 | 7 | 206 | 240 | $194,349 | $27,871 |
| 2020 | 3 | 101 | 108 | $87,063 | $10,340 |
Total Patients
873
Total Services
1,002
Medicare Billing
$134,837
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 152 | 195 | $167,310 | $20,346 | 12.2% |
| 50543 | Partial removal of kidney using an endoscope | Facility | 2023 | 15 | 15 | $147,900 | $18,975 | 12.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 47 | 47 | $63,920 | $8,270 | 12.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 43 | $41,280 | $6,511 | 15.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 36 | 36 | $39,060 | $4,942 | 12.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 22 | 23 | $11,684 | $1,775 | 15.2% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 11 | 14 | $2,100 | $142.52 | 6.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 100 | 131 | $112,398 | $14,513 | 12.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 51 | 51 | $69,360 | $9,894 | 14.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 38 | 40 | $38,400 | $6,094 | 15.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 33 | 33 | $35,805 | $4,687 | 13.1% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 13 | 14 | $1,277 | $358.08 | 28.0% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2022 | 11 | 12 | $1,800 | $118.64 | 6.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 63 | 73 | $62,634 | $8,150 | 13.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 28 | 28 | $38,080 | $5,156 | 13.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 32 | 32 | $34,720 | $4,569 | 13.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 43 | $21,844 | $3,337 | 15.3% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 12 | 15 | $16,875 | $3,326 | 19.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 19 | 20 | $19,200 | $3,232 | 16.8% |
| 81002 | Urinalysis, manual test | Office | 2021 | 14 | 29 | $996.00 | $100.92 | 10.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 37 | 37 | $40,145 | $4,948 | 12.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 30 | 31 | $26,598 | $2,723 | 10.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 34 | 40 | $20,320 | $2,669 | 13.1% |
About Dr. Brian Shuch, MD
Dr. Brian Shuch, MD is a Urology healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2008. The National Provider Identifier (NPI) number assigned to this provider is 1134370422.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Shuch, MD has received a total of $168,175 in payments from pharmaceutical and medical device companies, with $45,447 received in 2024. These payments were reported across 139 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($56,680).
As a Medicare-enrolled provider, Shuch has provided services to 873 Medicare beneficiaries, totaling 1,002 services with total Medicare billing of $134,837. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Los Angeles, CA
- Active Since 10/05/2008
- Last Updated 01/09/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1134370422
Products in Payments
- ILLUCCIX (Drug) $51,244
- KEYTRUDA (Biological) $23,048
- WELIREG (Drug) $18,593
- SUTENT (Drug) $6,269
- OPDIVO (Biological) $3,579
- Da Vinci Surgical System (Device) $2,041
- FOTIVDA (Drug) $302.78
- AQUABEAM ROBOTIC SYSTEM (Device) $205.42
- STRAVIX (Medical Supply) $144.01
- OSTEOCOOL RF ABLATION (Device) $132.74
- AMS 700 CXR RTE KIT (Device) $110.24
- Emprint (Device) $94.23
- Bard Urinary Drainage Bag (Device) $66.18
- TISSEEL (Device) $43.41
- MYRBETRIQ (Drug) $36.93
- BOTOX (Biological) $34.49
- DIREXION (Device) $23.81
- TISSEEL (Biological) $17.33
- COOK (Device) $13.28
- Urgent PC (Device) $9.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Los Angeles
Mihir Desai, M.d, M.D
Urology — Payments: $1.6M
Urology $1.6M
Arie Belldegrun, Md, MD
Urology — Payments: $1.3M
Urology $1.3M
Dr. William Aronson, Md, MD
Urology — Payments: $753,306
Urology $753,306
Dr. Stuart Holden
Urology — Payments: $668,127
Urology $668,127
Dr. Siamak Daneshmand, M.d, M.D
Urology — Payments: $317,876
Urology $317,876
Dr. Jeffrey Loh-Doyle, M.d, M.D
Urology — Payments: $295,721
Urology $295,721